tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Aurinia Pharmaceuticals Approves New Equity Incentive Plan
PremiumCompany AnnouncementsAurinia Pharmaceuticals Approves New Equity Incentive Plan
2M ago
Aurinia Pharmaceuticals: Strong Buy Rating Backed by Robust Financials and Promising Pipeline
Premium
Ratings
Aurinia Pharmaceuticals: Strong Buy Rating Backed by Robust Financials and Promising Pipeline
2M ago
Aurinia Pharmaceuticals Reports Strong Q1 2025 Earnings
Premium
Company Announcements
Aurinia Pharmaceuticals Reports Strong Q1 2025 Earnings
2M ago
Aurinia Pharmaceuticals backs FY25 revenue view $250M-$260M
PremiumThe FlyAurinia Pharmaceuticals backs FY25 revenue view $250M-$260M
2M ago
Aurinia Pharmaceuticals Reports Strong First Quarter 2025 Financial Results
Premium
Company Announcements
Aurinia Pharmaceuticals Reports Strong First Quarter 2025 Financial Results
2M ago
Aurinia Pharmaceuticals to Announce Q1 2025 Results
Premium
Company Announcements
Aurinia Pharmaceuticals to Announce Q1 2025 Results
3M ago
AUPH Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsAUPH Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
Insider Moves: Semtech, BioMarin, Yum!, Tenaya, Aurinia
Premium
Weekend Updates
Insider Moves: Semtech, BioMarin, Yum!, Tenaya, Aurinia
4M ago
Aurinia Pharmaceuticals: Strong Financial Performance and Strategic Positioning Justify Buy Rating
Premium
Ratings
Aurinia Pharmaceuticals: Strong Financial Performance and Strategic Positioning Justify Buy Rating
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100